ANGN - Angion Biomedica: Interesting New IPO With Late Stage Asset Targeting A Novel Indication April, 16 2021 01:55 PM Angion Biomedica Corp. Angion is a recent IPO. It has an ongoing phase 3 trial with near-term data readout. Cash balance is a little low. For further details see: Angion Biomedica: Interesting New IPO With Late Stage Asset Targeting A Novel Indication